{
  "titleTemplate": {
    "templateType": "HTML",
    "templateText": "$title",
    "variables": [
      {
        "name": "title",
        "translations": [
          {
            "language": "en",
            "text": "What will the patient have to do if I permit them to take part in the DCP?"
          }
        ]
      }
    ]
  },
  "bodyTemplate": {
    "templateType": "HTML",
    "templateText": """
      <p>$text</p>
      <details class="ddp-learn-more">
        <summary>Learn more</summary>
        <p class="ddp-toggleable ddp-toggleable--hidden" id="whatsnext-learn-more">$learnmore</p>
      </details>
    """,
    "variables": [
      {
        "name": "text",
        "translations": [
          {
            "language": "en",
            "text": """
              The DCP collects and stores data. At this point, we do not expect patients who are unable to consent to
              take any action.
            """
          }
        ]
      },
      {
        "name": "learnmore",
        "translations": [
          {
            "language": "en",
            "text": """
              It is likely that in the future, DCP will expand to include the collection of biosamples such as
              saliva or blood. At that time, RARE-X would request an additional consent to take part in that process.
            """
          }
        ]
      }
    ]
  },
  "blockType": "CONTENT",
  "shownExpr": null
}
